Callodine Capital Management, LP Bristol Myers Squibb CO Transaction History

Callodine Capital Management, LP

$394 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $289,450 - $323,650	-5,000 Reduced 4.17%	115,000 $6.67 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $2.23 Million - $2.48 Million	35,000 Added 41.18%	120,000 $7.67 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $328,549 - $372,650	5,000 Added 6.25%	85,000 $5.89 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $5.82 Million - $6.89 Million	-85,000 Reduced 51.52%	80,000 $5.76 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $12,025 - $7.11 Million	92,500 Added 127.59%	165,000 $11.7 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $13.3 Million - $14.6 Million	-182,500 Reduced 71.57%	72,500 $5.58 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $922,200 - $1.11 Million	-15,000 Reduced 5.56%	255,000 $18.6 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.61 Million - $1.88 Million	-30,000 Reduced 10.0%	270,000 $16.8 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $1.33 Million - $1.56 Million	22,500 Added 8.11%	300,000 $17.8 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $928,650 - $1.01 Million	15,000 Added 5.71%	277,500 $18.5 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $3.71 Million - $4.17 Million	62,500 Added 31.25%	262,500 $16.6 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $1.77 Million - $2 Million	30,625 Added 18.08%	200,000 $12.4 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $1.18 Million - $1.31 Million	-20,625 Reduced 10.86%	169,375 $10.2 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $11.2 Million - $13.1 Million	-205,000 Reduced 51.9%	190,000 $11.2 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $3.94 Million - $5.73 Million	85,000 Added 27.42%	395,000 $22 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $1.97 Million - $2.57 Million	40,000 Added 14.81%	310,000 $19.9 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $8.98 Million - $10.6 Million	210,000 Added 350.0%	270,000 $13.7 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $2.68 Million - $2.96 Million	60,000 New	60,000 $2.72 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callodine Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Callodine Capital Management, LP with notifications on news.

Account